Correlation between renin-angiotensin system and Severe Acute Respiratory Syndrome Coronavirus 2 infection: What do we know?

European Journal of Pharmacology
Antonio Vitiello, Francesco Ferrara

Abstract

The first cases of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2 or COVID-19) infections were recorded in China in November 2019. Since its appearance in China at the end of last year, the virus has spread to all continents causing a "global pandemic". To date, some aspects remain to be investigate about the pathophysiology of this viral infection. One of the aspects to be still clarified is the correlation between the renin-angiotensin system (RAS) and SARS-CoV-2 infection. RAS is a physiological system playing a key role in different human body functions regulation. SARS-CoV-2 uses the angiotensin-converting enzyme 2 (ACE-2), a component of RAS, as a potential factor of cell penetration and infectivity; in addition, in the different infection stages, a functional variation of the RAS has been noted. In this article, we discuss the correlation between the role of RAS and system-modifying agents, angiotensin-converting enzyme inhibitors (ACEIs), angiotensin II receptor blockers (ARBs) and direct renin inhibitors (DRIs), with SARS-CoV-2 infection.

References

Jul 12, 2002·Journal of Neuroscience Research·Yong B LeeSeung U Kim
Jul 8, 2005·Nature·Yumiko ImaiJosef M Penninger
Nov 22, 2007·Journal of Managed Care Pharmacy : JMCP·Steven A Atlas
Nov 21, 2007·Molecular Medicine·Rodrigo Araújo Fraga-SilvaRobson Augusto Souza Santos
Jul 27, 2011·Clinics·Rodrigo Araujo Fraga-SilvaRobson A S Santos
Oct 8, 2011·Arteriosclerosis, Thrombosis, and Vascular Biology·Suguru YamamotoValentina Kon
Jul 31, 2013·The Journal of Surgical Research·Qiuhua ChenHaibo Qiu
Oct 31, 2013·American Journal of Respiratory Cell and Molecular Biology·Ying MengXu Li
Jan 7, 2015·British Journal of Pharmacology·G S MagalhãesM J Campagnole-Santos
Apr 3, 2019·Journal of Cardiovascular Development and Disease·Ali NehmeKazem Zibara
Mar 7, 2020·Nature Reviews. Cardiology·Ying-Ying ZhengXiang Xie
Mar 15, 2020·The Lancet. Respiratory Medicine·Lei FangMichael Roth
Mar 21, 2020·European Heart Journal·Gabriela M KusterStefan Osswald
Apr 1, 2020·The New England Journal of Medicine·Muthiah VaduganathanScott D Solomon
Apr 4, 2020·JAMA Cardiology·Chirag BavishiFranz H Messerli

❮ Previous
Next ❯

Citations

Sep 3, 2020·SN Comprehensive Clinical Medicine·Antonio VitielloFrancesco Ferrara
Jan 15, 2021·Naunyn-Schmiedeberg's Archives of Pharmacology·Francesco Ferrara, Antonio Vitiello
Feb 8, 2021·Respiratory Medicine·Antonio Vitiello, Francesco Ferrara
Nov 19, 2020·Irish Journal of Medical Science·Antonio Vitiello, Francesco Ferrara
Dec 4, 2020·BMJ Evidence-based Medicine·Antonio VitielloFrancesco Ferrara
Mar 30, 2021·Wiener klinische Wochenschrift·Francesco Ferrara, Antonio Vitiello
Apr 21, 2021·Wiener klinische Wochenschrift·Antonio Vitiello, Francesco Ferrara
May 2, 2021·Inflammopharmacology·Antonio Vitiello, Francesco Ferrara

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.